NCT01589510 A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Status COMPLETED Phase N/A
NCT01568008 Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Status COMPLETED Phase N/A
NCT01547598 Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction Status COMPLETED Phase PHASE4
NCT01540370 Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT) Status COMPLETED Phase N/A
NCT01528787 Study of AR-13324 in Patients With Elevated Intraocular Pressure Status COMPLETED Phase PHASE2
NCT01528111 Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT01525173 A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension Status COMPLETED Phase PHASE4
NCT01520116 Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension Status UNKNOWN Phase PHASE1/PHASE2
NCT01491867 Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect Status COMPLETED Phase NA
NCT01489670 Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase N/A
NCT01474135 AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure Status COMPLETED Phase PHASE2
NCT01467440 Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines Status UNKNOWN Phase N/A
NCT01467388 Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients Status UNKNOWN Phase N/A
NCT01464424 Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) Status COMPLETED Phase PHASE4
NCT01452009 Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% Status WITHDRAWN Phase PHASE3